Pancreatic cancer is the fourth leading cause of cancer-related death in both men and women in the US, researchers said.
The overall occurrence of pancreatic cancer has not significantly changed since 2002, but the mortality rate has increased annually from 2002 to 2011, according to the US National Cancer Institute.
"Pancreatic cancer is really unique and different from other cancers," said study co-author Ka He, at the Indiana University School of Public Health-Bloomington.
Previous studies have found that magnesium is inversely associated with the risk of diabetes, which is a risk factor of pancreatic cancer.
More From This Section
However, few studies have explored the direct association of magnesium with pancreatic cancer; of those that did, their findings were inconclusive, said Daniel Dibaba, a PhD student at the School of Public Health-Bloomington, who led the study.
The researchers analysed data on over 66,000 men and women, ages 50 to 76, looking at the direct association between magnesium and pancreatic cancer and whether age, gender, body mass index, non-steroidal anti-inflammatory drugs use and magnesium supplementation play a role.
The study also found that the effects of magnesium on pancreatic cancer did not appear to be modified by age, gender, body mass index or non-steroidal anti-inflammatory drug use, but was limited to those taking magnesium supplements either from a multivitamin or individual supplement.
"For those at a higher risk of pancreatic cancer, adding a magnesium supplement to their diet may prove beneficial in preventing this disease," Dibaba said.
The study was published in the British Journal of Cancer.